Logo image of RR

RICHTECH ROBOTICS INC-CL B (RR) Stock Fundamental Analysis

NASDAQ:RR - Nasdaq - US7655041058 - Common Stock - Currency: USD

2.34  -0.08 (-3.31%)

Premarket: 2.37 +0.03 (+1.28%)

Fundamental Rating

3

RR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. No worries on liquidiy or solvency for RR as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, RR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RR had negative earnings in the past year.
RR had a negative operating cash flow in the past year.
RR Yearly Net Income VS EBIT VS OCF VS FCFRR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

RR has a Return On Assets of -21.62%. This is amonst the worse of the industry: RR underperforms 85.16% of its industry peers.
With a Return On Equity value of -22.11%, RR is not doing good in the industry: 78.91% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -21.62%
ROE -22.11%
ROIC N/A
ROA(3y)-12.12%
ROA(5y)N/A
ROE(3y)-14.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RR Yearly ROA, ROE, ROICRR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

1.3 Margins

RR has a Gross Margin of 74.61%. This is amongst the best in the industry. RR outperforms 100.00% of its industry peers.
RR's Gross Margin has improved in the last couple of years.
RR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.85%
GM growth 5YN/A
RR Yearly Profit, Operating, Gross MarginsRR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

8

2. Health

2.1 Basic Checks

RR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RR has more shares outstanding
RR has a better debt/assets ratio than last year.
RR Yearly Shares OutstandingRR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
RR Yearly Total Debt VS Total AssetsRR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 125.61 indicates that RR is not in any danger for bankruptcy at the moment.
RR's Altman-Z score of 125.61 is amongst the best of the industry. RR outperforms 100.00% of its industry peers.
There is no outstanding debt for RR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 125.61
ROIC/WACCN/A
WACC9.83%
RR Yearly LT Debt VS Equity VS FCFRR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

RR has a Current Ratio of 75.74. This indicates that RR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of RR (75.74) is better than 100.00% of its industry peers.
A Quick Ratio of 73.23 indicates that RR has no problem at all paying its short term obligations.
RR has a better Quick ratio (73.23) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 75.74
Quick Ratio 73.23
RR Yearly Current Assets VS Current LiabilitesRR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

RR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -301.40%.
The Revenue for RR has decreased by -51.07% in the past year. This is quite bad
RR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.08% yearly.
EPS 1Y (TTM)-301.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.1%
Revenue 1Y (TTM)-51.07%
Revenue growth 3Y-11.08%
Revenue growth 5YN/A
Sales Q2Q%0.17%

3.2 Future

RR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.07% yearly.
Based on estimates for the next years, RR will show a very strong growth in Revenue. The Revenue will grow by 77.92% on average per year.
EPS Next Y-10.61%
EPS Next 2Y33.04%
EPS Next 3Y18.07%
EPS Next 5YN/A
Revenue Next Year76.49%
Revenue Next 2Y107.86%
Revenue Next 3Y77.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RR Yearly Revenue VS EstimatesRR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
RR Yearly EPS VS EstimatesRR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.02 -0.04 -0.06 -0.08 -0.1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RR Price Earnings VS Forward Price EarningsRR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RR Per share dataRR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

RR's earnings are expected to grow with 18.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.04%
EPS Next 3Y18.07%

More info and screens

0

5. Dividend

5.1 Amount

RR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RICHTECH ROBOTICS INC-CL B

NASDAQ:RR (6/5/2025, 8:07:23 PM)

Premarket: 2.37 +0.03 (+1.28%)

2.34

-0.08 (-3.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.72%
Inst Owner Change172.73%
Ins Owners3.82%
Ins Owner Change-2.04%
Market Cap268.63M
AnalystsN/A
Price TargetN/A
Short Float %18.74%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)16.67%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)24.53%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 61.16
P/FCF N/A
P/OCF N/A
P/B 4.81
P/tB 5.78
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.04
BVpS0.49
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.62%
ROE -22.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.61%
FCFM N/A
ROA(3y)-12.12%
ROA(5y)N/A
ROE(3y)-14.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.85%
GM growth 5YN/A
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 75.74
Quick Ratio 73.23
Altman-Z 125.61
F-Score4
WACC9.83%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-301.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.1%
EPS Next Y-10.61%
EPS Next 2Y33.04%
EPS Next 3Y18.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-51.07%
Revenue growth 3Y-11.08%
Revenue growth 5YN/A
Sales Q2Q%0.17%
Revenue Next Year76.49%
Revenue Next 2Y107.86%
Revenue Next 3Y77.92%
Revenue Next 5YN/A
EBIT growth 1Y-1126.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-116.24%
EBIT Next 3Y18.53%
EBIT Next 5YN/A
FCF growth 1Y-542.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-298.23%
OCF growth 3YN/A
OCF growth 5YN/A